Table 6 Lipid & Glycaemic changes in patients with baseline TG < 200 mg/dl

From: Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes

Total number of patients = 5

Lab Parameters

Baseline (Mean ± SD)

At Follow-up (Mean ± SD)

Change in Mean**

Triglycerides (mg/dL)

187.80 ± 10.06 mg/dL

106.20 ± 37.23 mg/dL

−81.60 mg/dL

Total Cholesterol (mg/dL)

150.80 ± 28.88 mg/dL

130.20 ± 22.34 mg/dL

−20.6 mg/dL

HDL (mg/dL)

37.00 ± 9.97 mg/dL

38.20 ± 8.35 mg/dL

+1.2 mg/dL

LDL (mg/dL)

88.60 ± 22.21 mg/dL

77.40 ± 20.02 mg/dL

−11.20 mg/dL

Non HDL (mg/dL)

113.80 ± 27.88 mg/dL

92.20 ± 17.58 mg/dL

−21.60 mg/dL

FPG (mg/dL)

168.40 ± 71.76 mg/dL

118.20 ± 22.47 mg/dL

−50.20 mg/dL

PPG (mg/dL)

255.80 ± 94.53 mg/dL

190.60 ± 82.66 mg/dL

−65.2 mg/dL

HbA1c (%)

7.94 ± 1.39%

7.34 ± 1.72%

−0.60%

Back to article page